Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study
Anita M Leys,1,2 Eva Ramboer,3 Mérédis Favreau,3 Kris Denhaerynck,4,5 Karen MacDonald,4 Ivo Abraham,4,6– 8 Heidi Brié3 1Department of Ophthalmology, Universitair Ziekenhuis Gasthuisberg, KULeuven, Leuven, Belgium; 2Oogartsen, Alken, Belgium; 3Novartis Pharma, Vilvoorde, Belgium; 4Matrix45, Tucson, AZ, USA; 5Department of Public Health, University of Basel, Basel, Switzerland; 6Center for Health Outcomes and Pharmacoeconomic Research, University of Arizona, Tucson, AZ, USA; 7Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA; 8Department of... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Original Research |
Erscheinungsdatum: | 2020 |
Verlag/Hrsg.: |
Dove Press
|
Schlagwörter: | Clinical Ophthalmology |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27311607 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://www.dovepress.com/long-term-ranibizumab-treatment-in-neovascular-age-related-macular-deg-peer-reviewed-fulltext-article-OPTH |